March 17, 2022 -- Illumina has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, U.K.
The latest investments included 4SR Biosciences, B4X, Cache DNA, CRISP-HR Therapeutics, NonExomics, Purpose Health, and Rethink Bio Private Limited. These startups focus on a variety of areas, including breakthrough therapeutics, diagnostics, DNA storage, mental wellness, and sustainable foods applications, according to the vendor.
Applications for the next global funding cycle are due by April 1. To learn more and apply, visit the accelerator site.